http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3773443-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ed6680158f5d72e28788bef5f82f77f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-75 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2019-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b6fe1212e4bf8c4cea31e5eacc224e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055313ab101c2ccad9bb7bbb3b67b585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3321b7b563f59912fa927c48f766f254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41198fcb63a91b97579c1fe6c5d951ae |
| publicationDate | 2021-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3773443-A1 |
| titleOfInvention | Use of a new composition for preventing or slowing the appearance of signs of inflammation |
| abstract | Disclosed is the use of a composition (C1) for preventing or slowing the appearance of unaesthetic signs associated with inflammation of the skin and/or scalp, or of eliminating such signs, said composition (C1) comprising, per 100% by mass: a) - from 60.0% by mass to 75.0% by mass of an organic solvent (SO) chosen from 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 1,3-butanediol, 1,2-butanediol, 2-methyl-2,4-pentanediol, 1,6-hexanediol, 1,8-octanediol, or a blend of the above compounds; b) - from 0.1 % by mass to 2.0% by mass of a composition (ES) comprising a mass quantity x1, expressed as mass equivalent of 1-O-(2-caffeyol) maloyl-3,5-O-dicaffeoylquinic acid, greater than or equal to 200 mg/g of at least one compound of general formula (I): in which Q1, Q 2, Q 3, Q 4 et Q independently of each other represent the hydroxyl radical or one of its salts or a radical selected among the caffeoyl, maloyl, caffeoyl maloyl and maloyl caffeoyl radicals, it being understood that at least one of these radicals Q1, Q 2, Q 3, Q 4 et Q represents neither the -OH radical nor one of its salts; and c) from 20.0% by mass to 35.0% by mass water. |
| priorityDate | 2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 867.